Top Markets
Coin of the day
REYON Pharmaceutical Co., Ltd. REYON Pharmaceutical Co., Ltd.

REYON Pharmaceutical Co., Ltd.

102460
주식 순위 #20565
Operating both domestically in South Korea and across international markets,... Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's diverse range of offerings addresses various therapeutic areas, including adrenal corticosteroids; angiotensin II receptor antagonists; anticholinergics; antiemetics; antihypertensives; anti-inflammatory enzymes; lipid-lowering, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer treatments; antispasmodics; benign prostatic hypertrophy therapies; cough and cold remedies; cardiac stimulants; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis medications; local anesthetics; migraine drugs; a variety of cardiovascular system drugs; medications for neuromuscular disorders; nootropics and neurotonics; non-steroidal anti-inflammatory drugs (NSAIDs); respiratory stimulants; skeletal muscle relaxants; and vasodilators. Established in 1955, REYON Pharmaceutical Co., Ltd. maintains its corporate headquarters in Seoul, South Korea.
주가
$6.92
시가총액
$126.95M
변동 (1일)
0.10%
변동 (1년)
-11.37%
국가
KR
거래 REYON Pharmaceutical Co., Ltd. (102460)

카테고리

REYON Pharmaceutical Co., Ltd. (102460)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
REYON Pharmaceutical Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
REYON Pharmaceutical Co., Ltd.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율